Details of the Drug

General Information of Drug (ID: DM1DVXB)

Drug Name

Ioflubenzamide (131I)

Synonyms

Solazed; Ioflubenzamide I-131; MIP-1104; MIP-1143; MIP-1144; MIP-1145; ZK-BA; Iodine-123-Solazed; Iodine-131-Solazed; MIP-1145-[123I]; MIP-1145-[131I]; Radiolabeled benzamides (melanoma), Bayer; Radiolabeled benzamides (melanoma), Molecular Insight; Iodine-123-ZK-BA; Iodine-131-ZK-BA; Melanin-targeting radiodiagnostic (melanoma), Bayer/Molecular Insight; Melanin-targeting radiotherapeutic (melanoma), Bayer/Molecular Insight; 123I-MIP-1145; 123I-Solazed; 123I-ZK-BA

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C21H25FIN3O3
Canonical SMILES: CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)NC(=O)C2=CC=C(C=C2)F)I
InChI: 1S/C21H25FIN3O3/c1-4-26(5-2)11-10-24-21(28)16-12-17(23)18(13-19(16)29-3)25-20(27)14-6-8-15(22)9-7-14/h6-9,12-13H,4-5,10-11H2,1-3H3,(H,24,28)(H,25,27)/i23+4
InChIKey: UPRRZQGAQRAODM-AWUWEVMDSA-N

Cross-matching ID

PubChem CID: 24828760
CAS Number: 1214283-52-9
TTD ID: D06SYN

References

1	ClinicalTrials.gov (NCT00747825) Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma. U.S. National Institutes of Health.